SC683595 AMENGUAL NEUROLOGIA LTD false 2024-01-01 2024-12-31 2024-12-31 false The principal activity of the company is veterinary activities SC683595 uk-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 SC683595 2024-01-01 2024-12-31 SC683595 uk-bus:RegisteredOffice 2024-01-01 2024-12-31 SC683595 2023-01-01 2023-12-31 SC683595 uk-bus:Micro-entities 2024-01-01 2024-12-31 SC683595 uk-bus:FullAccounts 2024-01-01 2024-12-31 SC683595 uk-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 SC683595 2024-12-31 SC683595 uk-core:WithinOneYear 2024-12-31 SC683595 uk-core:AfterOneYear 2024-12-31 SC683595 2023-12-31 SC683595 uk-core:WithinOneYear 2023-12-31 SC683595 uk-core:AfterOneYear 2023-12-31 SC683595 uk-bus:Director1 2024-01-01 2024-12-31 SC683595 uk-bus:Director1 2024-12-31 iso4217:GBP shares pure
Registered number: SC683595
AMENGUAL NEUROLOGIA LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
AMENGUAL NEUROLOGIA LTD

BALANCE SHEET
AS AT 31 DECEMBER 2024
2024 2023
£ £
Fixed assets 375 975
Current assets 117,350 110,438
Creditors: amounts falling due within one year (3,164) (7,215)
Net current assets / (liabilities) 114,186 103,223
Total assets less current liabilities 114,561 104,198
Net assets / (net liabilities) 114,561 104,198
Capital and reserves 114,561 104,198

Notes to the financial statements:

  1. Average number of employees

    During the year the average number of employees, including directors, was 1 (2023: 1).

AMENGUAL NEUROLOGIA LTD (SC683595) is a private company limited by shares incorporated in Scotland. The registered office address is 10 GENF, Kyle Ct, Main Street, Glasgow, G72 7JH, Scotland.

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with section 476 of the Companies Act 2006.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with micro-entity provisions and with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies' regime. The income statement has not been delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 8 March 2025  and are signed on its behalf by:

Juan Carlos Serra Varela
Director
Company registration number: SC683595